Friday, July 25, 2025

Creating liberating content

BENGALURU: Swiggy has appointed Faraz Khalid, CEO of MidEast ecommerce

India’s foreign exchange reserves declined by $1.183 billion to $695.489

Related News

BENGALURU: Swiggy has appointed Faraz Khalid, CEO of MidEast ecommerce major noon, as an independent director to its board, while long-time investor nominees from Accel and SoftBank have exited their

The Atal Pension Yojana (APY), the Centre’s flagship social security scheme aimed at unorganised sector workers, has surpassed 8 crore total gross enrolments, the Finance Ministry said on Friday. The

Gold rate today: Gold prices fell for the second consecutive session on Friday, dropping Rs 500 to Rs 99,120 per 10 grams in Delhi’s bullion market amid easing global trade

India’s foreign exchange reserves declined by $1.183 billion to $695.489 billion during the week ended July 18, according to data released by the Reserve Bank of India (RBI) on Friday.This

India was unable to secure a carve-out from the UK’s upcoming carbon tax regime under the newly signed Free Trade Agreement (FTA), a shortcoming that could hurt Indian exports of

Access Denied You don’t have permission to access ” on this server. Reference #18.4cfdd417.1753443154.2a4eadc Source link

Trending News

BENGALURU: Swiggy has appointed Faraz Khalid, CEO of MidEast ecommerce major noon, as an independent director to its board, while long-time investor nominees from Accel and SoftBank have exited their

The Atal Pension Yojana (APY), the Centre’s flagship social security scheme aimed at unorganised sector workers, has surpassed 8 crore total gross enrolments, the Finance Ministry said on Friday. The

Access Denied You don’t have permission to access ” on this server. Reference #18.4cfdd417.1753443154.2a4eadc Source link

Pharmaceutical major Cipla posted a 10% year-on-year increase in consolidated net profit at Rs 1,298 crore for the quarter ended June 30, 2025, aided by solid demand in domestic and

India has reached its target of blending 20% ethanol with petrol five years ahead of schedule, according to the Indian Sugar & Bio-energy Manufacturers Association (ISMA).This marks a major leap

Alphabet Inc.’s strong earnings on Wednesday added to its explosive rally since early 2023, pushing its market value up by over $1 trillion and delivering a 120% return to investors.The

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore

Word Count: 578 | Estimated Reading Time: 3 minutes


Sun Pharma to acquire US oncology compony for over Rs 3,000 crore

Sun Pharma, India’s largest drugmaker, is acquiring Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million (over Rs 3,000 crore).
The acquisition will bolster the company’s specialty portfolio.
Checkpoint is a commercial-stage company that develops novel treatments for patients with solid tumor cancers, and the acquisition includes UNLOXCYT, an FDA-approved treatment for advanced skin cancer, says a company statement.
Dilip Shanghvi, CMD of Sun Pharma, said, “Combining UNLOXCYT, an FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, with Sun Pharma’s global presence means patients may soon have access to an important, new treatment option. The acquisition further bolsters our innovative portfolio in onco-derm therapy.”
James Oliviero, president and chief executive officer of Checkpoint, said, “This transaction will maximise value for our stockholders and provide accelerated access to UNLOXCYT in the United States, Europe and other markets worldwide.”
Upon completion of the transaction, Sun Pharma will acquire all outstanding shares of Checkpoint and Checkpoint stockholders will receive, for each share of common stock they hold, an upfront cash payment of $4.1.
The transaction is subject to Checkpoint’s shareholder and regulatory approvals and is expected to be completed in Q2CY25
In connection with the transaction, Checkpoint, Sun Pharma and Fortress Biotech, Checkpoint’s controlling stockholder, have entered into a royalty agreement, under which following the closing of the transaction, Fortress would be entitled to receive royalty payments based on future sales of cosibelimab during a specified term, in lieu of royalty rights that were granted to Fortress.





Source link

Most Popular Articles